Clincosm LogoSign in Get a demo

CONNAITRE: Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study

Sponsor
Direction des Soins de Santé de Base (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04384614
Collaborator
Eshmoun Clinical Research Center (Other), Dacima Consulting (Other)
0
Enrollment
1
Location
2
Anticipated Duration (Months)
0
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Covid-19 In Tunisia: AN Observational Cross-Sectional Registry Study

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Test PCR
  • Genetic: TDR
  • Other: Clinical Examination

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
0 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study Multicentric Study
Anticipated Study Start Date :
May 15, 2020
Anticipated Primary Completion Date :
Jul 15, 2020
Anticipated Study Completion Date :
Jul 15, 2020

Arms and Interventions

Arm Intervention/Treatment
COVID (+)

Patients COVID19(+) confirmed by PCR

Diagnostic Test: Test PCR
Viral load (COVID+) testing by PCR

Genetic: TDR
IDR and blood sampling for testing DNA Cheque

Other: Clinical Examination
COVID 19 symptoms and Physical Examination
COVID (-)

Patients COVID19 (-) who had been in contact with COVID-19 (+) confirmed by PCR

Diagnostic Test: Test PCR
Viral load (COVID+) testing by PCR

Genetic: TDR
IDR and blood sampling for testing DNA Cheque

Other: Clinical Examination
COVID 19 symptoms and Physical Examination

Outcome Measures

Primary Outcome Measures

  1. Differences related to epidemiological demographic characteristics [30 days]

    Identify differences related to epidemiological demographic characteristics and the profile of COVID(+) vs. the profile of COVID(-) patients who have been in contact with COVID(+) Vaccination History Questionnaire Medical and Surgical History Questionnaire Clinical Examination TDR and blood sampling for DNA Checks

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • COVID-19 (+), inpatient or outpatient, confirmed by PCR test

  • COVID-19 (-) confirmed by PCR test having been in contact with COVID-19 (+)

Exclusion Criteria:

  • COVID(+) and COVID(-) diagnosed by other tests than PCR

  • COVID-19 (-) Not having been in contact with COVID19(+)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eshmoun Clinical Research Centre Tunis Tunisia

Sponsors and Collaborators

  • Direction des Soins de Santé de Base
  • Eshmoun Clinical Research Center
  • Dacima Consulting

Investigators

  • Principal Investigator: Agnès Hamzaoui, Pr, Hopital Abderrahmane Mami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Agnès Hamzaoui, Head of department, Abderrahmane Mami Hospital
ClinicalTrials.gov Identifier:
NCT04384614
Other Study ID Numbers:
  • ECC2020-07
First Posted:
May 12, 2020
Last Update Posted:
Aug 27, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Agnès Hamzaoui, Head of department, Abderrahmane Mami Hospital
covid 19
BCG Vaccination
Additional relevant MeSH terms:
COVID-19

Study Results

No Results Posted as of Aug 27, 2020